Trials / Completed
CompletedNCT02032251
Reduction of Sperm DNA Fragmentation by Oral Ginger
Reduction of Sperm DNA Fragmentation by Oral Ginger (Zingiberofficinale) Extract Treatment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- Royan Institute · Other Government
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study is a randomized, double blind, controlled clinical trials assess the efficacy of the ginger oral treatment on sperm DNA fragmentation, sperm parameters and male hormones.
Detailed description
Sperm DNA fragmentation is known to affect male fertility. Previous findings have suggested the implication of oxidative stress in the etiology of this pathological condition. The present study was designed to find out DNA fragmentation in ejaculated spermatozoa can be reduced by oral treatment with Ginger extract. 71 men with unexplained or Idiopathic infertility were randomized between a Ginger treatment (500 milligram daily for 3months) group and a placebo group. Sperm DNA fragmentation was evaluated by Terminal deoxyribonucleotidyltransferase-mediated dUTP nick-end labeling assay (TUNEL) before and after treatment. No differences in basic sperm parameters were found between the Ginger treatment and the placebo group before or after treatment. However, the percentage of DNA-fragmented spermatozoa was markedly reduced (P\< .005) in the Ginger treatment group after the treatment as compared with the pretreatment values). No difference in the pretreatment and post treatment incidence of sperm DNA fragmentation was observed in the placebo group. These data show that sperm DNA damage can be efficiently treated with oral Ginger extract administered during a relatively short time period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oral administration of ginger | Oral administration of ginger in patients with infertility. |
| DRUG | Placebo |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-09-01
- Completion
- 2010-11-01
- First posted
- 2014-01-09
- Last updated
- 2014-01-09
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT02032251. Inclusion in this directory is not an endorsement.